License

License Not Specified

Other Access

The information on this page (the dataset metadata) is also available in these formats.

JSON RDF

via the DKAN API

A Phase 3 Multicenter Randomized Double-blind Study Comparing the Safety and Efficacy of Two Dosing Regimens of ABT-874 to Methotrexate in Subjects with Moderate to Severe Chronic Plaque Psoriasis

To compare the long-term clinical efficacy safety and tolerability of two dosing regimens of ABT-874 compared to MTX in the treatment of moderate to severe chronic plaque psoriasis over a 52-week period

FieldValue
Modified
2019-12-23
Release Date
2019-05-10
Identifier
055708d6-c69b-4a82-b0e3-21407b5f735e
License
License Not Specified
Public Access Level
Public